Thermo Fisher Scientific Inc
TMO- Latest Trade
- trading lower564.29USD
- -9.34
- 1.63%
- As of Jan 31 2023. Values delayed up to 15 minutes
- Day Range
- 560.76 - 570.87
- 52-Week Range
- 475.77 - 618.36
- Previous Close
- 573.63
- Open
- 567.77
- Volume
- 1,221,470.00
- 3 Month Average Trading Volume
- 32.35
- Shares Out (Mil)
- 392.20
- Market Cap
- 224,975.10
- Forward P/E
- 24.88
- Dividend Yield
- 0.21
Key Statistics
2 mean rating - 28 analysts
- P/E Excl. Extra Items (TTM)
- 32.24
- Price To Sales (TTM)
- 5.09
- Price To Book (Quarterly)
- 5.17
- Price To Cash Flow (Per Share TTM)
- 21.61
- Total Debt/Total Equity (Quarterly)
- 66.96
- Long Term Debt/Equity (Quarterly)
- 64.64
- Return On Investment (TTM)
- 9.92
- Return On Equity (TTM)
- 8.76
2021 (millions USD)
About Thermo Fisher Scientific Inc (TMO)
Company Information
Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company segments include Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Company offers its products and services through various brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines. Analytical Instruments segment provides a broad offering of instruments, consumables, software and services that are used for applications in the laboratory. Specialty Diagnostics segment offers a wide range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Services segment offers products and solutions needed for the laboratory.
Address
168 Third AvenueWALTHAM, MA
02451
United States
Industry
Medical Equipment & Supplies
Executive Leadership
- Marc N. Casper
- Chairman of the Board, President, Chief Executive Officer
- Stephen Williamson
- Chief Financial Officer, Senior Vice President
- Michel Lagarde
- Chief Operating Officer, Executive Vice President
- Gianluca Pettiti
- Executive Vice President
- Michael A. Boxer
- Senior Vice President, General Counsel, Secretary
- Joseph Holmes
- Chief Accounting Officer, Vice President
- Scott M. Sperling
- Lead Independent Director
- Tyler Jacks
- Director
- Nelson J. Chai
- Independent Director
- Ruby R. Chandy
- Independent Director
- C. Martin Harris
- Independent Director
- R. Alexandra Keith
- Independent Director
- Jim P. Manzi
- Independent Director
- James C. Mullen
- Independent Director
- Lars Rebien Sorensen
- Independent Director
- Debora L. Spar
- Independent Director
- Dion J. Weisler
- Independent Director
Financials
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,925.50 | 0.14% |
| Copper | 781.95 | 0.17% |
| Brent Crude Oil | 85.18 | 0.33% |
| CBOT Soybeans | 1,534.75 | 0.03% |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,017.77 | 1.30% |
| Euro STOXX 50 | 4,158.63 | 0.46% |
| FTSE 100 | 7,784.87 | 0.25% |
| Nikkei 225 | 27,396.50 | 0.13% |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes